Antiplasmodial, anti-complement and anti-inflammatory in vitro effects of Biophytum umbraculum Welw. traditionally used against cerebral malaria in Mali. (22nd August 2016)

• Record Type: Journal Article
• Authors: Austarheim, Ingvild; Pham, Anh Thu; Nguyen, Celine; Zou, Yuan-Feng; Diallo, Drissa; Malterud, Karl Egil; Wangensteen, Helle
• Is Part Of: Journal of ethnopharmacology. Volume 190(2016)
• Page Start: 159
• Page End: 164
• Publication Date: 2016-08-22
• Subjects: CM cerebral malaria -- EtOAc ethyl acetate -- MeOH methanol -- BuOH butanol -- DCM dichloromethane -- SI Selectivity Index -- RAW 264.7 murine macrophage cell line -- NO Nitric Oxide; Cerebral malaria (CM) -- Biophytum umbraculum -- Antiplasmodial, malaria -- Anti-complement -- Flavone C-glycosides; Ethnopharmacology -- Periodicals; Pharmacognosy -- Periodicals; Herbs -- Periodicals; Herbs -- Periodicals; Pharmacognosy -- Periodicals; Pharmacognosie -- Périodiques; Herbes -- Périodiques; 615.1
• DOI: 10.1016/j.jep.2016.05.058
• Languages: English
• ISSNs: 0378-8741

Abstract

Abstract: Ethnopharmacological relevance: Biophytum umbraculum Welw. (Oxalidaceae) is a highly valued African medicinal plant used for treatment of cerebral malaria, a critical complication of falciparum malaria. Aim of the study: To provide additional information about traditional use of B. umbraculum and to test plant extracts and isolated compounds for in vitro activities related to cerebral malaria. Materials and methods: The traditional practitioners were questioned about indication, mode of processing/application, dosage and local name of B. umbraculum . Organic extracts and some main constituents of the plant were investigated for anti-malaria, anti-complement activity and inhibition of NO secretion in a RAW 264.7 cell line. Results: Treatment of cerebral malaria was the main use of B. umbraculum (fidelity level 56%). The ethyl acetate extract showed anti-complement activity (ICH50 5.7±1.6 μg/ml), inhibition of macrophage activation (IC50 16.4±1.3 μg/ml) and in vitro antiplasmodial activity (IC50 K1 5.6±0.13 μg/ml, IC50 NF54 6.7±0.03 μg/ml). The main constituents (flavone C -glycosides) did not contribute to the activity of the extract. Conclusion: Inhibition of complement activation and anti-inflammatory activity of B. umbraculum observed in this study might be possible targets for adjunctive therapy in cerebral malaria together with its antiplasmodial activity. However, clinical trials are necessary to evaluate the activity due to the complex pathogenesis of cerebral malaria. Graphical abstract: